Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Novartis
Cerilliant
Accenture
McKinsey
QuintilesIMS
Moodys
Citi
Healthtrust
Mallinckrodt

Generated: October 22, 2017

DrugPatentWatch Database Preview

Pentostatin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pentostatin and what is the scope of pentostatin patent protection?

Pentostatin
is the generic ingredient in two branded drugs marketed by Hospira Inc, West-ward Pharms Int, and Mylan Institutional, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for pentostatin. One supplier is listed for this compound.

Summary for Generic Name: pentostatin

US Patents:0
Tradenames:2
Applicants:3
NDAs:3
Drug Master File Entries: see list2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list32
Clinical Trials: see list55
Patent Applications: see list7,987
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pentostatin at DailyMed

Pharmacology for Ingredient: pentostatin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
PENTOSTATIN
pentostatin
INJECTABLE;INJECTION077841-001Aug 7, 2007APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
PENTOSTATIN
pentostatin
INJECTABLE;INJECTION203554-001Sep 19, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
NIPENT
pentostatin
INJECTABLE;INJECTION020122-001Oct 11, 1991APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pentostatin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira Inc
NIPENT
pentostatin
INJECTABLE;INJECTION020122-001Oct 11, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Fuji
Cerilliant
UBS
Chinese Patent Office
Merck
Teva
Fish and Richardson
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot